RV
Rakesh Verma
About Rakesh Verma
Data last updated:
Rakesh Verma is a Director at Alesgute Laboratories (Opc) Private Limited (since 2019). The companies operate in Chemicals, Trading and Food And Beverages. Alesgute Laboratories (Opc) Private Limited reported revenue of ₹10 Lakh (FY 2025). Earlier, Rakesh Verma was a Director at Bellis Biotech Private Limited (2011–2019) and Director at Akticon Laboratories Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alesgute Laboratories (Opc) Private Limited U24290UP2019OPC115536 | Director | 04 Apr 2019 | 2019 | ₹10 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Bellis Biotech Private Limited U51109KA2011PTC059385 | Director | 29 Jun 2011 | 2011 | ₹33.4 Lakh (FY 2016) | Strike Off |
| Akticon Laboratories Private Limited U24304PB2018PTC047427 | Director | 02 Feb 2018 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Verma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Verma
Rakesh Verma currently holds 1 directorship: Alesgute Laboratories (Opc) Private Limited (Director, since 04 Apr 2019, revenue ₹10 Lakh (FY 2025)).
Rakesh Verma was first appointed on 29 Jun 2011 as Director at Bellis Biotech Private Limited. The most recent appointment on record is 04 Apr 2019 at Alesgute Laboratories (Opc) Private Limited.
Rakesh Verma held 2 earlier board appointments: Bellis Biotech Private Limited (Director, 29 Jun 2011 to 14 Jun 2019); Akticon Laboratories Private Limited (Director, 02 Feb 2018 to 06 Nov 2019).